FID-F 37-2590 MBQ/ml solution for injection FIDELIO
Active substance: fludeoxyglucose (18F)
V09IX04 Various | Tumour detection | Other diagnostic radiopharmaceuticals for tumour detection
Indicated for: diagnostic imaging
Find medicines for human use by name or active substance.
Browse by initial
321–340 of 836 medicines
Active substance: fludeoxyglucose (18F)
V09IX04 Various | Tumour detection | Other diagnostic radiopharmaceuticals for tumour detection
Indicated for: diagnostic imaging
Active substance: radiopharmaceuticals
V09GA01 Various | Cardiovascular system | Technetium (99mtc) compounds
Indicated for: diagnostic imaging
Active substance: radiopharmaceuticals
V09GA01 Various | Cardiovascular system | Technetium (99mtc) compounds
Indicated for: diagnostic imaging
Active substance: sodium iodide (131I)
V10XA01 Various | Other therapeutic radiopharmaceuticals | Iodine (131i) compounds
Indicated for: thyroid disorders; radioiodine therapy
Active substance: sodium iodide (131I)
V10XA01 Various | Other therapeutic radiopharmaceuticals | Iodine (131i) compounds
Indicated for: thyroid disorders; radioiodine therapy
Active substance: sodium iodide (131I)
V10XA01 Various | Other therapeutic radiopharmaceuticals | Iodine (131i) compounds
Indicated for: thyroid disorders; radioiodine therapy
Active substance: sodium iodide (131I)
V10XA01 Various | Other therapeutic radiopharmaceuticals | Iodine (131i) compounds
Indicated for: thyroid disorders; radioiodine therapy
Active substance: sodium iodide (131I)
V10XA01 Various | Other therapeutic radiopharmaceuticals | Iodine (131i) compounds
Indicated for: thyroid disorders; radioiodine therapy
Active substance: sodium iodide (131I)
V10XA01 Various | Other therapeutic radiopharmaceuticals | Iodine (131i) compounds
Indicated for: thyroid disorders; radioiodine therapy
Active substance: sodium iodide (131I)
V10XA01 Various | Other therapeutic radiopharmaceuticals | Iodine (131i) compounds
Indicated for: thyroid disorders; radioiodine therapy
Active substance: sodium iodide (131I)
V10XA01 Various | Other therapeutic radiopharmaceuticals | Iodine (131i) compounds
Indicated for: thyroid disorders; radioiodine therapy
Active substance: sodium iodide (131I)
V10XA01 Various | Other therapeutic radiopharmaceuticals | Iodine (131i) compounds
Indicated for: thyroid disorders; radioiodine therapy
Active substance: fidaxomycin
A07AA12 Alimentary tract and metabolism | Intestinal antiinfectives | Antibiotics
Indicated for: bacterial infections
Active substance: dapagliflozin
Indicated for: type 2 diabetes; heart failure; chronic kidney disease
Active substance: dapagliflozin
Indicated for: type 2 diabetes; heart failure; chronic kidney disease
Active substance: sparsentan
C09XX01 Cardiovascular system | Other agents acting on the renin-angiotensin system
Indicated for: IgA nephropathy
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.